|
Morphological characteristics of renal allografts showing renal dysfunction under FK 506 therapy: is graft biopsy available to reveal the morphological findings corresponding with FK 506 nephropathy? Japanese FK 506 Study Group. |
1993 |
Transplant. Proc. |
pmid:7679824
|
Kato H et al. |
Spontaneous proliferation of peripheral blood mononuclear cells as an indicator for insufficient plasma levels of FK 506 in the early phase after liver transplantation. |
1994 |
Transplant. Proc. |
pmid:7513481
|
Jain AB et al. |
FK 506 dosage in human organ transplantation. |
1990 |
Transplant. Proc. |
pmid:1689890
|
Morris RE |
In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use. |
1991 |
Transplant. Proc. |
pmid:1721257
|
Loss M et al. |
Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy. |
1996 |
Transplant. Proc. |
pmid:8623210
|
Fougeray S et al. |
Increased body mass index after kidney transplantation in activating transcription factor 6 single polymorphism gene carriers. |
2011 |
Transplant. Proc. |
pmid:22099811
|
Tang J et al. |
Cytokine Profile in Calcineurin Inhibitor-Induced Chronic Nephrotoxicity in Chinese Liver Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27788813
|
Wachtman GS et al. |
Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine. |
2011 |
Transplant. Proc. |
pmid:22099837
|
Fitzsimmons WE et al. |
Demographic considerations in tacrolimus pharmacokinetics. |
1998 |
Transplant. Proc. |
pmid:9636552
|
Jang HJ et al. |
Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis. |
2000 |
Transplant. Proc. |
pmid:11119904
|
Burke GW et al. |
Tacrolimus-related microangiopathy in kidney and simultaneous pancreas-kidney recipients: evidence of endothelin and cytokine involvement. |
1998 |
Transplant. Proc. |
pmid:9532223
|
Berman M et al. |
Lipid metabolism and immunosuppressive therapy in heart transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12644091
|
Marcén R et al. |
Evolution of rejection rates and kidney graft survival: a historical analysis. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715918
|
Lauzurica R et al. |
Monotherapy with tacrolimus and corticosteroid withdrawal. |
2002 |
Transplant. Proc. |
pmid:11959217
|
Rilo HR et al. |
Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. |
1993 |
Transplant. Proc. |
pmid:7680172
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment. |
1993 |
Transplant. Proc. |
pmid:7680173
|
Blanc P et al. |
Antiproliferative effect of FK 506 and cyclosporine on adult human hepatocytes in culture. |
1991 |
Transplant. Proc. |
pmid:1721288
|
Ueno M et al. |
Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation. |
1992 |
Transplant. Proc. |
pmid:1373546
|
Yasunami Y et al. |
Characterization of the immunosuppressive activity of FK 506 in rat islet allografts. |
1990 |
Transplant. Proc. |
pmid:1691557
|
Loréal O et al. |
FK 506 is less cytotoxic than cyclosporine to human and rat hepatocytes in vitro. |
1991 |
Transplant. Proc. |
pmid:1721289
|
Matsuzaki T et al. |
Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats. |
1992 |
Transplant. Proc. |
pmid:1373547
|
D'Silva M et al. |
Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623467
|
Pirenne J et al. |
Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623472
|
Maggard M et al. |
Incidence of acute rejection in African-American liver transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636607
|
Yamaguchi M et al. |
FK 506 significantly improves transferred insulin gene expression in total pancreatectomized dogs. |
2000 |
Transplant. Proc. |
pmid:11120255
|
Mueller AR et al. |
Influence of immunosuppression on patient outcome after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636608
|
Yoshida S et al. |
Combination therapy with FK 506 and RS61443 for rejection following allogeneic small bowel transplantation in rats. |
2000 |
Transplant. Proc. |
pmid:11120262
|
Morales JM et al. |
Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid. |
1999 |
Transplant. Proc. |
pmid:10576051
|
Jordan ML et al. |
Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up. |
1999 |
Transplant. Proc. |
pmid:10576052
|
Mano A et al. |
Reversible myocardial hypertrophy induced by tacrolimus in a pediatric heart transplant recipient: case report. |
2009 |
Transplant. Proc. |
pmid:19917396
|
Nishikawa S et al. |
Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease. |
2009 |
Transplant. Proc. |
pmid:19917404
|
Lampreabe I et al. |
Toward personalized medicine in renal transplantation. |
2010 |
Transplant. Proc. |
pmid:20970553
|
Pérez-Flores I et al. |
Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus. |
2010 |
Transplant. Proc. |
pmid:20970565
|
Sato K et al. |
Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249521
|
Marzorati S et al. |
Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249555
|
Nishimori H et al. |
Combination therapy with FK 506 and splenectomy may induce tolerance in cardiac xenografts. |
1994 |
Transplant. Proc. |
pmid:7518102
|
Kawauchi M et al. |
Cardiac xenotransplantation from pig to Japanese monkey with splenectomy, tacrolims, filtration plasmapheresis, and nafamstat mesilate. |
1994 |
Transplant. Proc. |
pmid:7518105
|
Woodle ES et al. |
FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease. |
1993 |
Transplant. Proc. |
pmid:7682360
|
Lang T et al. |
Distinct patterns of Th2 cytokine production during immune activation in pediatric liver allograft recipients. |
1995 |
Transplant. Proc. |
pmid:7533367
|
Chen-Woan M et al. |
Diminished lymphocyte growth from endomyocardial biopsies from cardiac transplant patients on FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721320
|
Wojewodzka J et al. |
Inhibition of formation of synapses between dendritic cells and lymphocytes in skin lymph in an allogeneic reaction by cyclosporine and tacrolimus. |
2003 |
Transplant. Proc. |
pmid:14529947
|
Suga A et al. |
Diabetes mellitus after renal transplantation under tacrolimus-based immunosuppression. |
2003 |
Transplant. Proc. |
pmid:12591391
|
Koefoed-Nielsen PB et al. |
Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients. |
2005 |
Transplant. Proc. |
pmid:15919449
|
Kumano K et al. |
Role of endothelin in FK 506-induced renal hypoperfusion in rats. |
1995 |
Transplant. Proc. |
pmid:7533423
|
Aguirrezabalaga J et al. |
Lipid profiles after liver transplantation in patients receiving tacrolimus or cyclosporin. |
2002 |
Transplant. Proc. |
pmid:12176480
|
Izutani H et al. |
Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration. |
1995 |
Transplant. Proc. |
pmid:7533425
|
Varo E et al. |
Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy. |
2002 |
Transplant. Proc. |
pmid:12176481
|
Green M et al. |
Infectious complications of pediatric liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721352
|
Torre-Cisneros J et al. |
The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721353
|
Gerauer K et al. |
Long-term cardiac allograft survival in mice treated with malononitrilamide 715. |
1998 |
Transplant. Proc. |
pmid:9865349
|
Odoul F et al. |
Massive ingestion of tacrolimus in a young liver transplant patient. |
1998 |
Transplant. Proc. |
pmid:9865375
|
Hossain MA et al. |
Immunosuppression in auxiliary partial liver transplantation with FK506 in rats. |
1997 |
Transplant. Proc. |
pmid:9414861
|
Weber M et al. |
Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy. |
1997 |
Transplant. Proc. |
pmid:9414883
|
Deniz H et al. |
Inhibition of the renin angiotensin system decreases fibrogenic cytokine expression in tacrolimus nephrotoxicity in rats. |
2006 |
Transplant. Proc. |
pmid:16549154
|
Fisniku O et al. |
Protective effects of PG490-88 on chronic allograft rejection by changing intragraft gene expression profiles. |
2005 |
Transplant. Proc. |
pmid:15919518
|
Jiménez O et al. |
Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation. |
2003 |
Transplant. Proc. |
pmid:12962758
|
Ciftci HS et al. |
Effect of MDR1 polymorphisms on the blood concentrations of tacrolimus in Turkish renal transplant patients. |
2013 |
Transplant. Proc. |
pmid:23622581
|
Jordan ML et al. |
Five-year experience with tacrolimus rescue for renal allograft rejection. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123009
|
Cronin DC et al. |
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123010
|
Teebken OE et al. |
Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12072335
|
Rossi G et al. |
Results of orthotopic liver-small bowel transplantation in the pig using different immunosuppressive regimens. |
1996 |
Transplant. Proc. |
pmid:8907932
|
Burke GW et al. |
Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection. |
2002 |
Transplant. Proc. |
pmid:12176505
|
Calia R et al. |
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation. |
2011 |
Transplant. Proc. |
pmid:21620041
|
|
Morphopathological findings of renal allografts under FK 506 therapy. Japanese FK 506 Study Group. |
1994 |
Transplant. Proc. |
pmid:7520614
|
McCauley J et al. |
Changes in renal function after liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721385
|
Morris RE et al. |
Immunopharmacology of FK-506. |
1989 |
Transplant. Proc. |
pmid:2468201
|
Tauxe WN et al. |
A comparison of the renal effects (ERPF, GFR, and FF) of FK 506 and cyclosporine in patients with liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721386
|
Humar A et al. |
Surgical complications requiring early relaparotomy after pancreas transplantation: comparison of the cyclosporine and FK 506 eras. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083256
|
Personett HA et al. |
Impact of molecular adsorbent recirculating system therapy on tacrolimus elimination: a case report. |
2014 |
Transplant. Proc. |
pmid:25017243
|
Grochowicz PM et al. |
Synergistic interaction between castanospermine and tacrolimus in a rat heart allograft model. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123296
|
Gerbase MW et al. |
Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation. |
2001 |
Transplant. Proc. |
pmid:11377481
|
Yussim A et al. |
Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. |
1996 |
Transplant. Proc. |
pmid:8962233
|
Sifontis NM et al. |
Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176554
|
Gerhardt U et al. |
High QT dispersion in tacrolimus-treated kidney transplant recipients. |
2001 |
Transplant. Proc. |
pmid:11377482
|
Golling M et al. |
Tacrolimus reduction improves glucose metabolism and insulin secretion after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8962234
|
Toda F et al. |
Tacrolimus trough level adjustment after administration of fluconazole to kidney recipients. |
2002 |
Transplant. Proc. |
pmid:12176555
|
Lee PC et al. |
Cyclosporine or tacrolimus: which is the better partner for myfortic or cellcept? |
2012 |
Transplant. Proc. |
pmid:22310598
|
Ju MK et al. |
A 6-month, open-label, multicenter clinical study in Korean de novo renal transplant patients evaluating the efficacy, safety, and tolerance of myfortic concomitantly used with tacrolimus. |
2012 |
Transplant. Proc. |
pmid:22310600
|
Fukuzaki T et al. |
Induction of tolerance to islet allografts with preoperative donor spleen cell injection and a short course of FK 506 treatment. |
1991 |
Transplant. Proc. |
pmid:1721415
|
Degawa H et al. |
Blocking of ICAM-1 and LFA-1 in rat liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8658695
|
Watanabe K et al. |
Immunosuppressive effect of bactobolamine in rat liver allotransplantation. |
1996 |
Transplant. Proc. |
pmid:8658697
|
Ciancio G et al. |
Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267169
|
Ozkurt S et al. |
Late effects of renal transplantation on endothelial functions and cardiac morphology. |
2011 |
Transplant. Proc. |
pmid:21911132
|
Pan D et al. |
Tacrolimus-associated Diffuse Gastrointestinal Ulcerations and Pathergy: A Case Report. |
|
Transplant. Proc. |
pmid:28104141
|
Alkhunaizi AM et al. |
Breast fibroadenomas in renal transplant recipients. |
2004 Jul-Aug |
Transplant. Proc. |
pmid:15350492
|
Lauro A et al. |
Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning? |
2005 |
Transplant. Proc. |
pmid:15964382
|
Alberti D et al. |
Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9723310
|
Flechner SM |
Minimizing calcineurin inhibitor drugs in renal transplantation. |
2003 |
Transplant. Proc. |
pmid:12742481
|
El-Sabrout R et al. |
Improved lipid profile and blood sugar control in pediatric renal transplant recipients using sirolimus-tacrolimus combination. |
2002 |
Transplant. Proc. |
pmid:12176638
|
Doesch AO et al. |
Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. |
2010 |
Transplant. Proc. |
pmid:21168673
|
Mohamed MA et al. |
TGF-beta expression in protocol transplant liver biopsies: a comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267336
|
Fabrega AJ et al. |
FK 506 enhances the beneficial effects of donor-specific blood transfusion on allograft survival in rats. |
1991 |
Transplant. Proc. |
pmid:1721447
|
Shokouh-Amiri MH et al. |
The importance of early prevention of renal dysfunction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267345
|
Davies CB et al. |
Effects of donor-specific transfusion, cyclosporine A and FK 506 on rat cardiac allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721448
|
Viebahn R et al. |
Simulation of hypoxic and preservation injury in human hepatocyte cultures: influence of FK 506 and cyclosporine. |
1993 |
Transplant. Proc. |
pmid:7689278
|
Dé P et al. |
Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? |
1993 |
Transplant. Proc. |
pmid:7689279
|
Alvarez-ElÃas AC et al. |
CYP3A5 Genotype and Time to Reach Tacrolimus Therapeutic Levels in Renal Transplant Children. |
2016 |
Transplant. Proc. |
pmid:27110018
|
Cofan F et al. |
Oxidation of low-density lipoproteins in renal transplant recipients. |
1999 |
Transplant. Proc. |
pmid:10500604
|
GarcÃa González M et al. |
Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation. |
1999 |
Transplant. Proc. |
pmid:10500620
|
Tanabe K et al. |
Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience. |
1998 |
Transplant. Proc. |
pmid:9636497
|